Lyndsey C Bolanos

7PUBLICATIONS
47CO-AUTHORS
Molecular targetsHaematological tumoursInnate immunityAutoimmunityMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 16, 2025
Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilization.

Eric J Vick, Aishlin Hassan, Kwangmin Choi

|Apr 24, 2025
Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1.

Puneet Agarwal, Avery Sampson, Kathleen Hueneman

|Apr 12, 2024
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression.

Shinichiro Matsui, Chihiro Ri, Lyndsey C Bolanos

|May 12, 2023
Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML.

Joshua Bennett, Chiharu Ishikawa, Puneet Agarwal

|Mar 09, 2022
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia.

Laura Barreyro, Avery M Sampson, Chiharu Ishikawa

|Sep 01, 2021
The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia.

Madeline Niederkorn, Chiharu Ishikawa, Kathleen M Hueneman

Pageof 2